Blood growth factor extraction device and information loading system

Abstract

The invention belongs to the technical field of medical equipment, and particularly relates to a blood growth factor extraction device and an information loading system.The blood growth factor extraction device comprises a box body used for connecting all components; the blood centrifugal assembly is arranged in the box body, and the blood centrifugal assembly is used for centrifugally removing red blood cells of the blood; the information field assembly is arranged in the box body, the information field assembly is connected with the blood centrifugal assembly, and the information field assembly is used for performing scalar wave action on blood in the blood centrifugal assembly and loading specific life factor information into plasma; the disinfection assembly is arranged in the box body, the disinfection assembly is connected with the blood centrifugal assembly, the disinfection assembly is used for disinfecting test tubes in the blood centrifugal assembly, and it is guaranteed that wound repair factors, blood platelets, growth factors and the like are more easily and sufficiently separated during separation and preparation.

Description

Technical Field

[0001] The invention relates to the technical field of blood extraction, in particular to a blood growth factor extraction device and an information loading system. Background Art

[0002] An important choice for clinical treatment. Blood growth factors (such as platelet-derived growth factor, transforming growth factor-β, etc.) play a pivotal role in tissue repair, regeneration and immune regulation. In particular, the application of blood growth factors in the fields of orthopedics, dentistry and cosmetic medicine has received extensive attention. They can promote the healing of damaged tissues by stimulating cell proliferation and differentiation.

[0003] Traditional methods for extracting blood growth factors generally rely on centrifugal separation technology. Although this method can separate plasma rich in growth factors to a certain extent, it still has many shortcomings in terms of extraction efficiency, purity and safety. With the in-depth study of the physiological effects and mechanisms of growth factors, existing extraction equipment and technologies have failed to fully meet clinical needs. Therefore, it is of great practical significance to develop an efficient, safe and intelligent blood growth factor extraction device and information loading system.

[0004] At present, the extraction and utilization of blood components at home and abroad are mostly mechanized, and there is still a lack of special designs for growth factors, as well as corresponding data management and analysis systems. Existing equipment generally has problems such as complex operation, decentralized information management, and low data integration, which brings inconvenience to medical staff and patient information transparency. In addition, the application of growth factors is often accompanied by the need for individualized treatment. How to combine the extraction effect of growth factors with the specific symptoms of patients has become an important topic in the development of clinical medicine.

[0005] In order to overcome the above shortcomings, a new blood growth factor extraction device is designed, and combined with an intelligent information loading system, through automated control, real-time data monitoring and analysis, efficient extraction and precise application of growth factors can be achieved. This integrated system can not only improve the extraction efficiency and safety of growth factors, but also provide timely clinical data references, providing a reliable basis for individualized treatment.

[0006] In view of the above-mentioned technical defects, a solution is now proposed. Summary of the invention

[0007] To solve the above problems, the present invention provides the following technical solutions:

[0008] A blood growth factor extraction device, comprising:

[0009] A box body, which is used for connecting various components;

[0010] A blood centrifuge assembly, which is disposed in the housing and is used for centrifugally removing red blood cells from the blood;

[0011] An information field component, the information field component is disposed in the box, the information field component is connected to the blood centrifugal component, and the information field component is used to perform scalar wave action on the blood in the blood centrifugal component and load specific life factor information into the plasma;

[0012] A disinfection component is disposed in the box, the disinfection component is connected to the blood centrifuge component, and the disinfection component is used to disinfect the test tubes in the blood centrifuge component.

[0013] Furthermore, the blood centrifuge assembly includes a PLC controller, a centrifuge dish, a leaky bucket and an output tube. The PLC controller is arranged at the bottom end of the box body. The PLC controller connects the centrifuge dish and the leaky bucket, and controls the centrifuge dish and the leaky bucket to rotate respectively or drives the centrifuge dish and the leaky bucket to operate synchronously. The leaky bucket is connected to the outer wall of the centrifuge dish. The box body is provided with a feed port, and the feed port is connected to the centrifuge dish. The leaky bucket and the centrifuge dish are both provided with through holes, and when the through holes overlap, the centrifuged plasma is transported. A guide barrel is provided in the box body, and the guide barrel is connected to the output tube to transport plasma. The guide barrel collects the plasma transmitted after the through holes overlap.

[0014] Furthermore, the information field component includes a scalar field generator and a scalar field encoder, the scalar field encoder is connected to a host computer, the scalar field encoder is used to set parameters of the scalar wave, the scalar field generator is arranged in the housing, the scalar field generator and the scalar field encoder are electrically connected to transmit the scalar wave to act on the blood, and load specific life factor information into the plasma.

[0015] Furthermore, the disinfection component includes an ultraviolet generator, an ultraviolet lamp tube and an ultraviolet light beam. The ultraviolet lamp tube is arranged in the box body, the ultraviolet generator is connected to the ultraviolet lamp tube, and the ultraviolet light beam is connected to the opening of the ultraviolet generator. The ultraviolet light beam is used to emit ultraviolet rays to disinfect the test tube in the centrifuge dish. The ultraviolet lamp tube moves up and down along the box body and disinfects the inner wall of the centrifuge dish.

[0016] According to another aspect of the present invention, there is provided an information loading system, comprising the blood growth factor extraction device described above, and further comprising:

[0017] Blood separation module, used to quickly separate the collected blood into plasma and blood cells, ensuring high-quality plasma samples for subsequent processing, and a piping system connecting the centrifuge and subsequent processing modules;

[0018] The information loading module is used to generate and regulate the autonomous information field, load specific life factor information into the plasma, and process and generate specific life factor information through built-in algorithms and hardware to ensure the accuracy and effectiveness of the information.

[0019] Scalar wave action module, a device that generates scalar waves, acts on blood samples to make them undergo an orderly self-organization process and release a large amount of growth factors. The scalar waves are guided and focused by a waveguide system to ensure that they act on the blood samples;

[0020] The control system is responsible for the operation and control of the entire device, including parameter setting, process control and data recording, and provides an operation interface to facilitate medical staff to operate and monitor the operating status of the device;

[0021] Safety module, which ensures that blood samples are not contaminated by external factors during processing, reduces the risk of infection, and disinfects the equipment before each use to ensure the hygiene and safety of the equipment;

[0022] The monitoring module monitors the parameters of each link in the processing process, including temperature and pressure, to ensure the stability and safety of the processing process, and records the key data in the processing process for subsequent analysis and optimization.

[0023] Furthermore, the information loading module retrieves a preset life factor information template from a storage unit according to treatment needs, runs an information processing algorithm through a microprocessor to generate specific life factor information, generates electromagnetic waves or scalar waves of specific frequency and intensity according to the generated information by the autonomous information field generator, guides the autonomous information field to the plasma sample through a waveguide system, applies the autonomous information field to the plasma sample, loads the life factor information into the plasma, monitors the information loading process in real time through a sensor array to ensure accurate transmission and effective loading of information, processes sensor data through a data analysis unit to confirm the accuracy and effectiveness of information loading, and fine-tunes the information loading process based on the monitoring results to ensure the best effect.

[0024] Furthermore, the scalar wave action module includes setting the frequency, intensity and wavelength of the scalar wave according to preset treatment needs and life factor information. The scalar field generator generates scalar waves of specific frequency and intensity according to the set parameters. The generated scalar wave is guided to the plasma sample through the waveguide system. The intensity and range of the scalar wave are adjusted by the focusing device to ensure that it covers the entire plasma sample. The scalar wave acts on the platelets in the plasma sample, causing them to undergo an orderly self-organization process and release a large amount of growth factors. The scalar wave activates the growth factors in the plasma, causing them to play a greater role in tissue repair and regeneration. The effect of the scalar wave is monitored in real time through the sensor array, including changes in electric field, temperature and optical properties. The sensor data is analyzed by the central processor to evaluate the effect of the scalar wave to ensure accurate transmission and effective loading of information.

[0025] Furthermore, the monitoring module includes:

[0026] The data acquisition unit includes a temperature sensor, a pressure sensor, a flow rate sensor, an electric field sensor and an optical sensor to monitor various parameters in the processing process in real time; collects the data monitored by the sensor and converts it into a digital signal through an analog-to-digital converter;

[0027] The data processing unit performs preliminary processing and storage of the collected data to ensure the integrity and traceability of the data; through the communication interface, the collected data is transmitted to the central control unit for further data analysis and processing;

[0028] The data analysis unit processes and analyzes the collected data in real time, evaluates the stability and safety of the processing process, generates monitoring reports and feedback information based on the analysis results, displays them on the display, and stores them in the storage unit;

[0029] The abnormal monitoring and alarm unit will send out an alarm signal to alert the operator when an abnormal situation is detected. The alarm light and buzzer will send out visual and auditory alarm signals to remind the operator to take corresponding measures. The alarm information and processing process will be recorded to facilitate subsequent analysis and improvement.

[0030] Furthermore, the data analysis includes setting the frequency of the scalar wave according to the preset treatment needs and life factor information to ensure that it can effectively activate the growth factor within a specific range. The calculation formula is as follows:

[0031]

[0032] Among them, f set is the set frequency, f base is the initial frequency, Δf demand is the percentage change in demand frequency;

[0033] According to the characteristics of the plasma sample and the treatment requirements, the intensity of the scalar wave is set to ensure that it acts on the plasma sample within an appropriate range. The calculation formula is as follows:

[0034]

[0035] Among them, E set To set the electric field strength, E base is the initial electric field strength, ΔE demand is the percentage change of required electric field strength;

[0036] The wavelength of the scalar wave is set to ensure that its wavelength matches the characteristics of the plasma sample to maximize the activation effect of the growth factor. The calculation formula is as follows

[0037]

[0038] Among them, λ set is the set wavelength, f set is the set frequency and c is the speed of light.

[0039] Furthermore, the data analysis includes guiding the generated scalar wave to the plasma sample through a waveguide system to ensure the transmission path and efficiency of the wave. The calculation formula is as follows:

[0040] η waveguide =η loss ·η focus ,

[0041] Among them, η waveguide is the waveguide system efficiency, η loss is the energy ratio of the scalar wave lost due to various loss factors when passing through the waveguide system, η focus To focus on efficiency;

[0042] The focusing device adjusts the intensity and range of the scalar wave to ensure that it covers the entire plasma sample and maximizes the effect of activating the growth factor, calculated as follows:

[0043]

[0044] Among them, Focus set To set the focus parameters, Focus base is the initial focusing parameter, ΔFocus demand Focus on the percentage change of the parameter for the needs;

[0045] The scalar wave acts on the plasma sample, especially the platelets, causing them to undergo an orderly self-organization process and release a large amount of growth factors. The calculation formula for the change in growth factor release is as follows:

[0046]

[0047] Among them, ΔG is the change in growth factor release, G base is the energy of the initial growth factor without scalar field stimulation, ΔG effect is the energy effect percentage of the growth factor acting on the scalar wave;

[0048] According to the scalar wave activation of growth factors in plasma, it plays a greater role in tissue repair and regeneration. The growth factor activation efficiency calculation formula is as follows:

[0049]

[0050] Among them, A growth is the growth factor activation efficiency, A base Growth factor activation efficiency without scalar field stimulation, ΔA effect Scalar wave action growth factor activation efficiency effect percentage.

[0051] Compared with the prior art, the present invention has the following beneficial effects:

[0052] 1. In a blood growth factor extraction device of the present invention, a box is used to connect various components; a blood centrifuge component, which is arranged in the box and is used to centrifuge and remove red blood cells from the blood; an information field component, which is arranged in the box and connected to the blood centrifuge component, which is used to perform scalar wave action on the blood in the blood centrifuge component and load specific life factor information into the plasma; a disinfection component, which is arranged in the box and connected to the blood centrifuge component, which is used to disinfect the test tubes in the blood centrifuge component, so as to ensure that the wound repair factors, platelets and growth factors can be separated more easily during separation and preparation;

[0053] 2. In an information loading system of the present invention, a blood separation module is used to quickly separate the collected blood into plasma and blood cells, ensuring high-quality plasma samples for subsequent processing, and a pipeline system connecting the centrifuge and the subsequent processing module ensures the smooth flow of blood samples; an information loading module is used to generate and regulate an autonomous information field, load specific life factor information into plasma, and process and generate specific life factor information through built-in algorithms and hardware to ensure the accuracy and effectiveness of the information. The scalar wave action module is a device that generates scalar waves. It acts on blood samples to make them undergo an orderly self-organization process and release a large amount of growth factors. The scalar waves are guided and focused through the waveguide system to ensure that they act on blood samples. The control system is responsible for the operation and control of the entire device, including parameter setting, processing flow control and data recording. It provides an operation interface to facilitate medical staff to operate and monitor the operation status of the equipment. The safety module ensures that blood samples are not contaminated by external factors during the processing process, reduces the risk of infection, and disinfects the equipment before each use to ensure the hygiene and safety of the equipment. The monitoring module monitors the parameters of each link in the processing process, including temperature, pressure, and flow rate, to ensure the stability and safety of the processing process, and records the key data in the processing process for subsequent analysis and optimization. It has the function of orderly operating the damaged information in the patient's body through the life information factor technology, adjusting it to a comfortable state and completing the self-organization process. Complete the regeneration of cells in the affected area to achieve the purpose of treatment and rehabilitation. BRIEF DESCRIPTION OF THE DRAWINGS

[0054] In order to facilitate understanding by those skilled in the art, the present invention is further described below in conjunction with the accompanying drawings;

[0055] Figure 1 This is an overall schematic diagram of a blood growth factor extraction device of the present invention;

[0056] Figure 2 It is a schematic diagram of the overall framework of an information loading system of the present invention;

[0057] Figure 3 A schematic diagram of the framework of a monitoring module in an information loading system of the present invention;

[0058] Figure 4 It is a schematic diagram of the framework of the information field component of a blood growth factor extraction device of the present invention;

[0059] Figure 5 This is an overall schematic diagram of Example 2 of a blood growth factor extraction device of the present invention.

[0060] Figure numerals: 1. housing; 2. blood centrifuge assembly; 21. PLC controller; 22. centrifuge dish; 23. leaky bucket; 24. output tube; 25. guide bucket; 3. information field assembly; 31. scalar field generator; 32. scalar field encoder; 4. disinfection assembly; 41. ultraviolet generator; 42. ultraviolet lamp tube; 43. ultraviolet lamp beam; 5. cooling assembly; 51. cooling box; 6. centrifuge device; 61. centrifuge cylinder; 62. centrifuge cover. DETAILED DESCRIPTION

[0061] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0062] like Figure 1-4 As shown, a blood growth factor extraction device comprises:

[0063] Box 1, blood centrifugal assembly 2, information field assembly 3 and disinfection assembly 4, box 1 is used to connect the various components; blood centrifugal assembly 2 is arranged in box 1, and blood centrifugal assembly 2 is used to centrifuge and remove red blood cells from the blood; information field assembly 3 is arranged in box 1, and information field assembly 3 is connected to blood centrifugal assembly 2, and information field assembly 3 is used to perform scalar wave action on the blood in blood centrifugal assembly 2, and load specific life factor information into the plasma; disinfection assembly 4 is arranged in box 1, and disinfection assembly 4 is connected to blood centrifugal assembly 2, and disinfection assembly 4 is used to disinfect the test tube in the blood centrifugal assembly 2. Using autonomous information field technology, life factor information is loaded into plasma, and the energy released regulates the cells of the material body and stimulates the body's self-healing ability. The scalar waves emitted by the independently developed scalar field generator 31 cause platelets to undergo an orderly self-organization process and release a large amount of growth factors. The white blood cells rich in growth factors can quickly reduce inflammatory lesions, so many patients with a large amount of fluid accumulation can see a reduction or even disappearance of the fluid accumulation within a short period of time (usually about 24 hours) after injection treatment, indicating that the inflammatory lesions have been rapidly improved. It can quickly improve the body's microenvironment, promote the induction of endogenous stem cells and immune activation responses, and current observations on the repair of tissues such as cartilage and gums have found that not only does it reduce pain, but it also achieves local tissue regeneration and reverse growth.

[0064] The blood centrifuge assembly 2 includes a PLC controller 21, a centrifuge dish 22, a leaky bucket 23 and an output tube 24. The PLC controller 21 is arranged at the bottom end of the box body 1. The PLC controller 21 connects the centrifuge dish 22 and the leaky bucket 23, and controls the centrifuge dish 22 and the leaky bucket 23 to rotate or drives the centrifuge dish 22 and the leaky bucket 23 to operate synchronously. The leaky bucket 23 is connected to the outer wall of the centrifuge dish 22. A feed port is arranged on the box body 1, and the feed port is connected to the centrifuge dish 22. The leaky bucket 23 and the centrifuge dish 22 are both provided with through holes, and when the through holes overlap, the centrifuged plasma is transported. A guide barrel 25 is arranged in the box body 1, and the guide barrel 25 is connected to the output tube 24 to transport plasma. The guide barrel 25 collects the plasma transmitted after the through holes overlap.

[0065] The information field component 3 includes a scalar field generator 31 and a scalar field encoder 32. The scalar field encoder 32 is connected to a host computer. The scalar field encoder 32 is used to set parameters for scalar waves. The scalar field generator 31 is arranged in the housing 1. The scalar field generator 31 and the scalar field encoder 32 are electrically connected to transmit scalar waves to act on blood and load specific life factor information into the plasma. The disinfection component 4 includes an ultraviolet generator 41, an ultraviolet lamp 42 and an ultraviolet light beam 43. The ultraviolet lamp 42 is arranged in the housing 1. The ultraviolet generator 41 is connected to the ultraviolet lamp 42. The ultraviolet light beam 43 is connected to the opening of the ultraviolet generator 41. The ultraviolet light beam 43 is used to emit ultraviolet rays to disinfect the test tubes in the centrifugal dish 22. The ultraviolet lamp 42 moves up and down along the housing 1 and disinfects the inner wall of the centrifugal dish 22. First, take 10ml of blood from the vein with a special blood collection tube, and put the collected blood into the Hangke Life Factor Information Preparation Device for preparation. In this process, the influence of the information field scalar wave on the blood and the separation of plasma are realized. After 3 minutes of preparation, the prepared plasma is injected into the patient's painful area. It is completed.

[0066] Core technology and system advantages:

[0067] Extremely high safety. Conventional blood purification must add anticoagulants during the preparation process, otherwise the platelets in the blood will be activated and coagulated into a jelly before centrifugation is completed, and the injection cannot be completed. When the anticoagulant is added and then injected, the blood components, especially the enzymes and RNA in it, are greatly damaged and the activity is greatly reduced. Our preparation technology does not add any anticoagulants or other foreign exogenous substances. The entire process of blood drawing, preparation, and separation is achieved using sterile Class III consumables. Even if it is accidentally injected into a blood vessel, there is no impact, which is safer.

[0068] Advanced technology. It is prepared from the patient's venous blood, peripheral blood or autologous arterial blood (radial artery and femoral artery), and comprehensive health management of blood viscosity, blood oxygen saturation, etc. is performed before blood collection to ensure that trauma repair factors, platelets and growth factors are more easily separated during separation and preparation.

[0069] Effectiveness of treatment. It is in liquid form when injected and can be injected through the thinnest 34G needle without coagulation. After entering the body, the platelets will automatically activate and release a large amount of growth factors, forming a culture medium that will continue to repair and improve in the body for many days. Unlike platelets prepared after adding anticoagulants, which are easier to metabolize in the body, anticoagulants will also have irreversible effects on effective components such as enzymes in the blood, affecting the treatment effect. Because the activity of growth factors is stronger, the treatment effect is more effective and lasting.

[0070] Convenience of preparation. It only takes about 10 minutes from preparation to treatment completion, and preparation can be completed with one-touch operation. At the same time, 4-5 ml PRP can be extracted from 10 ml of blood.

[0071] Practicality of deployment. The entire process of blood drawing, separation and treatment uses medical devices in a sterile and closed environment. Preparation and treatment do not require a dedicated operating room environment. Only basic diagnosis and treatment environments such as ultraviolet disinfection are required for operation. At the same time, a dedicated sterile workbench can be selected to allow the entire separation and preparation process to be performed in a sterile environment, which is convenient for application in primary medical institutions.

[0072] According to another aspect of the present invention, there is provided an information loading system, comprising the above-mentioned blood growth factor extraction device, and further comprising:

[0073] Blood separation module, used to quickly separate the collected blood into plasma and blood cells, ensuring high-quality plasma samples for subsequent processing, and a piping system connecting the centrifuge and subsequent processing modules;

[0074] The information loading module is used to generate and regulate the autonomous information field, load specific life factor information into the plasma, and process and generate specific life factor information through built-in algorithms and hardware to ensure the accuracy and effectiveness of the information.

[0075] Scalar wave action module, a device that generates scalar waves, acts on blood samples to make them undergo an orderly self-organization process and release a large amount of growth factors. The scalar waves are guided and focused by a waveguide system to ensure that they act on the blood samples;

[0076] The control system is responsible for the operation and control of the entire device, including parameter setting, process control and data recording, and provides an operation interface to facilitate medical staff to operate and monitor the operating status of the device;

[0077] Safety module, which ensures that blood samples are not contaminated by external factors during processing, reduces the risk of infection, and disinfects the equipment before each use to ensure the hygiene and safety of the equipment;

[0078] The monitoring module monitors the parameters of each link in the processing process, including temperature and pressure, to ensure the stability and safety of the processing process, and records the key data in the processing process for subsequent analysis and optimization.

[0079] In one embodiment, 10 ml of blood is drawn from a patient's vein in preparation for subsequent processing.

[0080] Blood preparation: The collected blood is placed in the "Hangke Life Factor Information Preparation Device" for processing. In this process, the system uses autonomous information field technology and scalar field generators to affect the blood through scalar waves to achieve plasma separation and growth factor activation.

[0081] Plasma injection: Once prepared, the processed plasma enriched with activated growth factors is injected into the patient’s painful area to promote local tissue repair and regeneration.

[0082] Special blood collection tube: used to collect blood samples from patients.

[0083] Hangke Life Factor Information Preparer: The core module is used to process the collected blood, including the loading of information, the action of scalar waves and the separation of plasma.

[0084] Scalar field generator: A device that generates scalar waves, which regulate the activity of platelets and growth factors, promoting self-organization and the release of growth factors.

[0085] Injection device: used to inject the processed plasma into a specific part of the patient.

[0086] Specifically, the information loading module retrieves a preset life factor information template from a storage unit according to treatment needs, generates specific life factor information by running an information processing algorithm through a microprocessor, generates electromagnetic waves or scalar waves of specific frequency and intensity according to the generated information by an autonomous information field generator, guides the autonomous information field into a plasma sample through a waveguide system, applies the autonomous information field to the plasma sample, loads the life factor information into the plasma, monitors the information loading process in real time through a sensor array to ensure accurate transmission and effective loading of information, processes sensor data through a data analysis unit to confirm the accuracy and effectiveness of information loading, and fine-tunes the information loading process based on the monitoring results to ensure the best effect.

[0087] In one embodiment, the autonomous information field generator generates and regulates the autonomous information field to load specific life factor information into the plasma. Using advanced algorithms and hardware, electromagnetic waves or scalar waves of specific frequencies and intensities are generated, which can carry the life factor information and transfer it into the plasma.

[0088] The information processing unit processes and generates specific life factor information to ensure the accuracy and effectiveness of the information, including:

[0089] Microprocessor: responsible for running information processing algorithms to generate specific life factor information.

[0090] Storage unit: stores preset information templates and parameters to ensure consistency and accuracy of each processing.

[0091] Communication module: exchanges data with the central control unit and other modules to ensure coordination and synchronization of information processing.

[0092] The waveguide system guides and focuses the autonomous information field to ensure that it can effectively act on the plasma sample. It is used to guide the autonomous information field to reach the plasma sample to ensure the accurate transmission of information. It adjusts and optimizes the intensity and range of the autonomous information field to ensure that it covers the entire plasma sample. It monitors the process of information loading in real time to ensure accurate transmission and effective loading of information. Sensors are distributed around the waveguide system and the plasma sample to detect the intensity and distribution of the autonomous information field in real time. It processes sensor data to ensure the accuracy and effectiveness of information loading.

[0093] The method of generating specific life factor information by running an information processing algorithm through a microprocessor includes data collection and preprocessing steps:

[0094] Collect biological sample data, such as plasma, tissue sections, etc.

[0095] Use sensors or detection devices to obtain physical and chemical information from biological samples.

[0096] The raw data is preprocessed, including denoising, filtering, normalization and other operations, to ensure the accuracy and consistency of the data.

[0097] algorithm:

[0098] Denoising algorithm: Use wavelet transform or Fourier transform to remove noise from the data.

[0099] Filtering algorithm: Filter the data using low-pass, high-pass or band-pass filters.

[0100] Normalization algorithm: Use Z-score normalization or Min-Max normalization method to scale the data to a specific range.

[0101] Feature extraction steps:

[0102] Extract key features from the preprocessed data.

[0103] Characteristics may include frequency, intensity, wavelength, time series patterns, etc.

[0104] algorithm:

[0105] Fourier transform: Convert time domain signals into frequency domain signals and extract frequency features.

[0106] Wavelet transform: extracts time-frequency domain features and is suitable for non-stationary signals.

[0107] Autoregressive model (AR model): extracts features of time series data.

[0108] Steps to generate life factor information:

[0109] The extracted features are input into the life factor information generation model.

[0110] The model generates specific life factor information based on the input features.

[0111] algorithm:

[0112] Machine learning models: such as support vector machine (SVM), random forest (RandomForest), neural network (NeuralNetwork), etc., used for classification or regression tasks.

[0113] Deep learning models: such as convolutional neural networks (CNN), recurrent neural networks (RNN), long short-term memory networks (LSTM), etc., are used to handle complex pattern recognition and prediction tasks.

[0114] Information processing and optimization steps:

[0115] The generated life factor information is further processed and optimized.

[0116] Including data fusion, multi-source data integration, optimization algorithm application, etc.

[0117] algorithm:

[0118] Data fusion algorithms: such as Kalman filtering and particle filtering, used to fuse multi-source data.

[0119] Optimization algorithms: such as genetic algorithm, particle swarm optimization algorithm, simulated annealing, etc., are used to optimize the generation process of life factor information.

[0120] Output and feedback steps:

[0121] The generated life factor information is output to a display device or a storage device.

[0122] Adjust and optimize the algorithm based on feedback information to improve accuracy and reliability.

[0123] algorithm:

[0124] Feedback control system: Use PID controller or other feedback control algorithms to make real-time adjustments to the generated life factor information.

[0125] Iterative learning algorithm: such as reinforcement learning algorithm, which continuously optimizes algorithm performance through iterative learning.

[0126] Specifically, the scalar wave action module includes setting the frequency, intensity and wavelength of the scalar wave according to preset treatment needs and life factor information. The scalar field generator generates scalar waves of specific frequency and intensity according to the set parameters. The generated scalar wave is guided to the plasma sample through the waveguide system. The intensity and range of the scalar wave are adjusted by the focusing device to ensure that it covers the entire plasma sample. The scalar wave acts on the platelets in the plasma sample to enable them to undergo an orderly self-organization process and release a large amount of growth factors. The scalar wave activates the growth factors in the plasma, enabling them to play a greater role in tissue repair and regeneration. The effect of the scalar wave is monitored in real time through the sensor array, including changes in electric field, temperature and optical properties. The sensor data is analyzed by the central processor to evaluate the effect of the scalar wave to ensure accurate transmission and effective loading of information.

[0127] In one embodiment, scalar waves are generated that can act on a plasma sample, especially platelets, causing them to undergo an orderly self-organization process and release a large amount of growth factors.

[0128] Technical principle: Utilize advanced electromagnetic wave generation technology to generate scalar waves of specific frequency and intensity. Scalar waves are a special form of wave that can penetrate matter and affect microscopic particles in it, especially in biological tissues, and can promote cell self-organization and the release of growth factors.

[0129] The waveguide system guides and focuses the scalar wave to ensure that it can effectively act on the plasma sample. It is used to guide the scalar wave to the plasma sample to ensure accurate transmission of the wave. It adjusts and optimizes the intensity and range of the scalar wave to ensure that it covers the entire plasma sample. The reflectors and lenses are used to adjust the direction and intensity of the scalar wave to ensure that it effectively acts on the target area.

[0130] The control unit controls the generation of scalar waves and the operation of the waveguide system to ensure the coordination and synchronization of the scalar wave action modules. The central processor is responsible for running the control algorithm to generate and regulate the parameters of the scalar waves, such as frequency, intensity and wavelength. The feedback system monitors the generation and effect of scalar waves in real time, and makes fine adjustments based on the monitoring results to ensure the best effect. The communication module exchanges data with other modules of the life factor information preparation device to ensure the coordination and synchronization of the entire system.

[0131] Sensor array: monitors the effects of scalar waves in real time to ensure they can effectively activate growth factors in plasma.

[0132] Components:

[0133] Electric field sensor: used to detect the changes in the electric field generated by the scalar wave and evaluate its impact on the plasma sample.

[0134] Temperature sensor: monitors temperature changes of plasma samples to ensure sample stability during processing.

[0135] Optical sensor: Evaluate the effect of scalar waves by detecting changes in the optical properties of plasma samples.

[0136] Furthermore, the monitoring module includes:

[0137] The data acquisition unit includes a temperature sensor, a pressure sensor, a flow rate sensor, an electric field sensor and an optical sensor to monitor various parameters in the processing process in real time; collects the data monitored by the sensor and converts it into a digital signal through an analog-to-digital converter;

[0138] The data processing unit performs preliminary processing and storage of the collected data to ensure the integrity and traceability of the data; through the communication interface, the collected data is transmitted to the central control unit for further data analysis and processing;

[0139] The data analysis unit processes and analyzes the collected data in real time, evaluates the stability and safety of the processing process, generates monitoring reports and feedback information based on the analysis results, displays them on the display, and stores them in the storage unit;

[0140] The abnormal monitoring and alarm unit will send out an alarm signal to alert the operator when an abnormal situation is detected. The alarm light and buzzer will send out visual and auditory alarm signals to remind the operator to take corresponding measures. The alarm information and processing process will be recorded to facilitate subsequent analysis and improvement.

[0141] In one embodiment, key parameters during the processing, such as temperature, pressure, flow rate, electric field changes, and optical properties of the plasma sample, are monitored in real time.

[0142] Components:

[0143] Temperature sensor: monitors temperature changes of blood samples and processing environment to ensure that the processing process is carried out within the appropriate temperature range.

[0144] Pressure sensor: monitors pressure changes during processing, such as blood separation and scalar wave action, to ensure stable operation of the system.

[0145] Flow rate sensor: monitors the flow rate of blood samples in the pipeline system to ensure smooth flow of blood samples without blockage.

[0146] Electric field sensor: monitors the changes in the electric field generated by the action of scalar waves and evaluates the impact of scalar waves on plasma samples.

[0147] Optical sensors: By detecting changes in the optical properties of plasma samples, the effects of treatments, such as the extent of growth factor activation, can be assessed.

[0148] The data acquisition unit collects the data monitored by the sensor array and performs preliminary processing and storage.

[0149] Components:

[0150] Analog-to-digital converter (ADC): Converts the analog signals collected by the sensor into digital signals to facilitate subsequent data processing and analysis.

[0151] Data storage unit: stores the collected data to ensure data integrity and traceability.

[0152] Communication interface: Exchange data with the central control unit and other modules to ensure data synchronization and coordination.

[0153] The data analysis unit analyzes and processes the collected data, evaluates the stability and safety of the processing process, and generates monitoring reports and feedback information.

[0154] Components:

[0155] Microprocessor: runs data analysis algorithms to process and analyze the collected data in real time.

[0156] Storage unit: stores preset reference data and analysis templates to ensure consistency and accuracy of each analysis.

[0157] Alarm system: Based on the analysis results, an alarm signal is issued to remind operators to pay attention to abnormal situations and take corresponding measures.

[0158] The display and alarm unit displays monitoring data and analysis results in real time and sends out alarm signals when abnormal conditions are detected.

[0159] Components:

[0160] Display: Displays sensor data and analysis results in real time, such as temperature, pressure, flow rate, electric field changes and other parameters.

[0161] Warning light and buzzer: When abnormal conditions are detected, visual and audible alarm signals are issued to alert operators.

[0162] Alarm recording system: records alarm information and processing process to facilitate subsequent analysis and improvement.

[0163] Specifically, the data analysis includes setting the frequency of the scalar wave according to the preset treatment needs and life factor information to ensure that it can effectively activate the growth factor within a specific range. The calculation formula is as follows:

[0164]

[0165] Among them, f set is the set frequency, f base is the initial frequency, Δf demand is the percentage change in demand frequency;

[0166] According to the characteristics of the plasma sample and the treatment requirements, the intensity of the scalar wave is set to ensure that it acts on the plasma sample within an appropriate range. The calculation formula is as follows:

[0167]

[0168] Among them, E set To set the electric field strength, E base is the initial electric field strength, ΔE demand is the percentage change of required electric field strength;

[0169] The wavelength of the scalar wave is set to ensure that its wavelength matches the characteristics of the plasma sample to maximize the activation effect of the growth factor. The calculation formula is as follows

[0170]

[0171] Among them, λ set is the set wavelength, f set is the set frequency and c is the speed of light.

[0172] In one embodiment, the main function of the frequency setting model is to ensure that the scalar wave can effectively activate the growth factor in the plasma within a specific frequency range. By adjusting the frequency, the activation effect of the growth factor can be maximized. Too high or too low a frequency may lead to insufficient or excessive activation of the growth factor, thereby affecting the treatment effect.

[0173] The experimental data are as follows:

[0174] Experiment number Fundamental frequency (kHz) Frequency change percentage (%) Set frequency (kHz) Growth factor activation effect 1 100 10 110 Significant 2 100 5 105 medium 3 100 20 120 over 4 100 -10 90 insufficient

[0175] The main function of the intensity setting model is to ensure that the scalar wave acts on the plasma sample within the appropriate intensity range to avoid insufficient or damaged growth factor activation due to insufficient or excessive intensity. The intensity setting directly affects the penetration and range of action of the scalar wave in the plasma sample.

[0176] The experimental data are as follows:

[0177] Experiment number Basic strength (V / m) Strength change percentage (%) Set intensity (V / m) Growth factor activation effect 1 10 20 12 Significant 2 10 10 11 medium 3 10 30 13 over 4 10 -10 9 insufficient

[0178] The main function of the wavelength setting model is to ensure that the wavelength of the scalar wave matches the characteristics of the plasma sample to maximize the activation effect of the growth factor. A wavelength that is too long or too short may cause different absorption and scattering effects of the scalar wave in the plasma sample, thus affecting the activation effect.

[0179] The experimental data are as follows:

[0180]

[0181]

[0182] Specifically, the data analysis includes guiding the generated scalar wave to the plasma sample through the waveguide system to ensure the transmission path and efficiency of the wave. The calculation formula is as follows:

[0183] η waveguide =η loss ·η focus ,

[0184] Among them, η waveguide is the waveguide system efficiency, η loss is the energy ratio of the scalar wave lost due to various loss factors when passing through the waveguide system, η focus To focus on efficiency;

[0185] The focusing device adjusts the intensity and range of the scalar wave to ensure that it covers the entire plasma sample and maximizes the effect of activating the growth factor, calculated as follows:

[0186]

[0187] Among them, Focus set To set the focus parameters, Focus base is the initial focusing parameter, ΔFocus demand Focus on the percentage change of the parameter for the needs;

[0188] The scalar wave acts on the plasma sample, especially the platelets, causing them to undergo an orderly self-organization process and release a large amount of growth factors. The calculation formula for the change in growth factor release is as follows:

[0189]

[0190] Among them, ΔG is the change in growth factor release, G base is the energy of the initial growth factor without scalar field stimulation, ΔG effect is the energy effect percentage of the growth factor acting on the scalar wave;

[0191] According to the scalar wave activation of growth factors in plasma, it plays a greater role in tissue repair and regeneration. The growth factor activation efficiency calculation formula is as follows:

[0192]

[0193] Among them, A growth is the growth factor activation efficiency, A base Growth factor activation efficiency without scalar field stimulation, ΔA effect Scalar wave action growth factor activation efficiency effect percentage.

[0194] In one embodiment, the main function of the waveguide system guiding model is to ensure that the scalar wave can be efficiently transmitted to the plasma sample by optimizing the efficiency of the waveguide system. The efficiency of the waveguide system directly affects the transmission path and energy loss of the scalar wave.

[0195] The experimental data are as follows:

[0196] Experiment number Loss efficiency Focusing efficiency Waveguide system efficiency Growth factor activation effect 1 0.9 0.8 0.72 Significant 2 0.8 0.8 0.64 medium 3 0.9 0.7 0.63 insufficient

[0197] The main function of the focus adjustment model is to ensure that the intensity and range of the scalar wave cover the entire plasma sample by adjusting the focusing parameters, thereby maximizing the effect of activating the growth factor. The focusing parameters directly affect the energy distribution and range of the scalar wave.

[0198] The experimental data are as follows:

[0199] Experiment number Basic focusing parameters Focus parameter change percentage (%) Setting focus parameters Growth factor activation effect 1 5 15 5.75 Significant 2 5 10 5.5 medium 3 5 20 6.0 over 4 5 -10 4.5 insufficient

[0200] The specific experiments based on scalar waves acting on plasma samples are as follows:

[0201] Experimental procedures

[0202] Plasma sample preparation:

[0203] Plasma samples were collected from healthy volunteers.

[0204] The plasma was separated by centrifugation to ensure that the sample was free of impurities.

[0205] Scalar wave parameter settings:

[0206] Set the frequency, intensity and wavelength.

[0207] The scalar wave is guided to reach the plasma sample through a waveguide system and a focus adjustment device.

[0208] Experimental implementation:

[0209] The plasma sample is placed in the area of ​​scalar wave action.

[0210] The scalar wave device was activated to act on the plasma sample. A blood sample of 10 ml of blood was placed in a test tube and centrifuged and loaded with scalar waves simultaneously in the information field to achieve the extraction of growth factors.

[0211] The action time and growth factor activation effect were recorded.

[0212] Growth factor detection:

[0213] ELISA and other methods were used to detect the concentration changes of growth factors in plasma.

[0214] Record the data and analyze them.

[0215] Four sets of experimental data are given for data comparison, and the specific examples are as follows:

[0216]

[0217] Effect of Frequency on Growth Factor Activation:

[0218] The changes in growth factor concentration in Experiment 1 (110kHz) and Experiment 2 (105kHz) were significantly higher than those in Experiment 3 (120kHz) and Experiment 4 (90kHz).

[0219] It shows that the growth factor activation effect is best when the frequency is in the range of 105-110kHz.

[0220] Effect of electric field strength on growth factor activation:

[0221] The changes in growth factor concentrations in Experiment 1 (12 V / m) and Experiment 2 (11 V / m) were significantly higher than those in Experiment 3 (13 V / m) and Experiment 4 (9 V / m).

[0222] This indicates that the growth factor activation effect is best when the electric field strength is in the range of 11-12 V / m.

[0223] Effects of waveguide system efficiency and focusing parameters on growth factor activation:

[0224] The change in growth factor concentration for the waveguide system efficiency and focusing parameter combination (0.72, 5.75) of Experiment 1 was significantly higher than that of the other groups.

[0225] It shows that the optimized combination of waveguide system efficiency and focusing parameters has a significant impact on the growth factor activation effect.

[0226] Through the above experimental parameter settings and data analysis, we can see the influence of scalar wave frequency, electric field strength, wavelength, waveguide system efficiency and focusing parameters on the activation effect of growth factors in plasma samples. The experimental results show that the appropriate combination of parameters can significantly improve the activation effect of growth factors, thereby promoting tissue repair and regeneration. In practical applications, the parameters of scalar waves should be precisely adjusted according to specific treatment needs and plasma sample characteristics to achieve the best treatment effect.

[0227] Through the comparison of the above experimental parameters, we can see the influence of different frequencies, intensities, wavelengths, waveguide system efficiency and focusing parameters on the activation effect of growth factors. The experimental results show that the appropriate combination of parameters can significantly improve the activation effect of growth factors, thereby better promoting tissue repair and regeneration. In practical applications, the parameters of the scalar wave should be precisely adjusted according to specific treatment needs and plasma sample characteristics.

[0228] Example 2

[0229] The difference between this embodiment and embodiment 1 is that the centrifugal device 6 includes a centrifugal cylinder 61 and a centrifugal cover 62. 10 ml of the patient's blood is extracted and placed in a test tube. The test tube is placed in the centrifugal cylinder 61 and the blood in the test tube is centrifuged to extract blood growth factors and plasma. The test tube is stored at a low temperature by arranging a cooling component 5 on the box body. The cooling component 5 includes a cooling box 51. The cooling box 51 arranged in the box body cools the test tube in the centrifugal cylinder 61, thereby ensuring the activity of the blood in the test tube.

[0230] The working principle of a blood growth factor extraction device and an information loading system of the present invention is as follows: a box is used for connecting various components; a blood centrifuge component, the blood centrifuge component is arranged in the box, and the blood centrifuge component is used for centrifugally removing red blood cells from the blood; an information field component, the information field component is arranged in the box, the information field component is connected to the blood centrifuge component, the information field component is used for performing scalar wave action on the blood in the blood centrifuge component, and loading specific life factor information into the plasma; a disinfection component, the disinfection component is arranged in the box, the disinfection component is connected to the blood centrifuge component, and the disinfection component is used for disinfecting the test tube in the blood centrifuge component, which has the function of ensuring that wound repair factors, platelets and growth factors are more easily separated during separation and preparation; a blood separation module is used for quickly separating the collected blood into plasma and blood cells, ensuring high-quality plasma samples for subsequent processing, and connecting the centrifuge and the pipeline system of the subsequent processing module to ensure smooth flow of the blood sample; an information loading module is used for generating and regulating an autonomous information field, loading specific life factor information into the plasma, and processing and generating specific life factor information through built-in algorithms and hardware to ensure the accuracy and effectiveness of the information. The scalar wave action module is a device that generates scalar waves. It acts on blood samples to make them undergo an orderly self-organization process and release a large amount of growth factors. The scalar waves are guided and focused through the waveguide system to ensure that they act on blood samples. The control system is responsible for the operation and control of the entire device, including parameter setting, processing flow control and data recording. It provides an operation interface to facilitate medical staff to operate and monitor the operation status of the equipment. The safety module ensures that blood samples are not contaminated by external factors during the processing process, reduces the risk of infection, and disinfects the equipment before each use to ensure the hygiene and safety of the equipment. The monitoring module monitors the parameters of each link in the processing process, including temperature, pressure, and flow rate, to ensure the stability and safety of the processing process, and records the key data in the processing process for subsequent analysis and optimization. It has the function of orderly operating the damaged information in the patient's body through the life information factor technology, adjusting it to a comfortable state and completing the self-organization process. Complete the regeneration of cells in the affected area to achieve the purpose of treatment and rehabilitation.

[0231] The preferred embodiments of the present invention disclosed above are only used to help explain the present invention. The preferred embodiments do not describe all the details in detail, nor do they limit the invention to only specific implementation methods. Obviously, many modifications and changes can be made according to the content of this specification. This specification selects and specifically describes these embodiments in order to better explain the principles and practical applications of the present invention, so that those skilled in the art can understand and use the present invention well. The present invention is limited only by the claims and their full scope and equivalents.

Claims

1. A blood growth factor extraction device, characterized in that: include: A box (1), wherein the box (1) is used for connecting various components; A blood centrifuge component (2), the blood centrifuge component (2) being arranged in the housing (1), and the blood centrifuge component (2) being used for centrifugally removing red blood cells from blood; An information field component (3), the information field component (3) being arranged in the housing (1), the information field component (3) being connected to the blood centrifugal component (2), the information field component (3) being used to perform a scalar wave action on the blood in the blood centrifugal component (2) and to load specific life factor information into the plasma; A disinfection component (4), the disinfection component (4) is arranged in the box (1), the disinfection component (4) is connected to the blood centrifuge component (2), and the disinfection component (4) is used to disinfect the test tubes in the blood centrifuge component (2).

2. A blood growth factor extraction device according to claim 1, characterized in that: The blood centrifuge assembly (2) comprises a PLC controller (21), a centrifuge dish (22), a leaky bucket (23) and an output tube (24). The PLC controller (21) is arranged at the bottom end of the housing (1). The PLC controller (21) is connected to the centrifuge dish (22) and the leaky bucket (23). The PLC controller (21) is connected to a stepping motor and controls the centrifuge dish (22) and the leaky bucket (23) to rotate or drives the centrifuge dish (22) and the leaky bucket (23) to rotate simultaneously. The invention relates to a method for carrying out a centrifugal centrifuge according to the present invention. The centrifugal centrifuge is operated in steps, wherein the leaky bucket (23) is connected to the outer wall of the centrifugal dish (22), the casing (1) is provided with a feed port, the feed port is communicated with the centrifugal dish (22), the leaky bucket (23) and the centrifugal dish (22) are both provided with through holes, and when the through holes overlap, the centrifuged plasma is transported, and a guide bucket (25) is provided in the casing (1), the guide bucket (25) is connected to the output tube (24) to transport the plasma, and the guide bucket (25) collects the plasma transmitted after the through holes overlap.

3. A blood growth factor extraction device according to claim 2, characterized in that: The information field component (3) includes a scalar field generator (31) and a scalar field encoder (32), wherein the scalar field encoder (32) is connected to a host computer and is used to set parameters of a scalar wave. The scalar field generator (31) is arranged in the housing (1), and the scalar field generator (31) and the scalar field encoder (32) are electrically connected to transmit a scalar wave to act on blood and load specific life factor information into the plasma.

4. A blood growth factor extraction device according to claim 3, characterized in that: The disinfection component (4) comprises an ultraviolet generator (41), an ultraviolet lamp tube (42) and an ultraviolet light beam (43); the ultraviolet lamp tube (42) is arranged in the housing (1); the ultraviolet generator (41) is connected to the ultraviolet lamp tube (42); the ultraviolet light beam (43) is connected to the opening of the ultraviolet generator (41); the ultraviolet light beam (43) is used to emit ultraviolet light to disinfect the test tube in the centrifugal dish (22); the ultraviolet lamp tube (42) moves up and down along the housing (1) and disinfects the inner wall of the centrifugal dish (22).

5. An information loading system, comprising the blood growth factor extraction device according to any one of claims 1 to 4, characterized in that: include: Blood separation module, used to quickly separate the collected blood into plasma and blood cells, ensuring high-quality plasma samples for subsequent processing, and a piping system connecting the centrifuge and subsequent processing modules; The information loading module is used to generate and regulate the autonomous information field, load specific life factor information into the plasma, and process and generate specific life factor information through built-in algorithms and hardware to ensure the accuracy and effectiveness of the information; Scalar wave action module, a device that generates scalar waves, acts on blood samples to make them undergo an orderly self-organization process and release a large amount of growth factors. The scalar waves are guided and focused by a waveguide system to ensure that they act on the blood samples; The control module is responsible for the operation and control of the entire device, including parameter setting, process control and data recording, and provides an operation interface to facilitate medical staff to operate and monitor the operating status of the device; Safety module, which ensures that blood samples are not contaminated by external factors during processing, reduces the risk of infection, and disinfects the equipment before each use to ensure the hygiene and safety of the equipment; The monitoring module monitors the parameters of each link in the processing process, including temperature and pressure, to ensure the stability and safety of the processing process, and records the key data in the processing process for subsequent analysis and optimization.

6. The information loading system according to claim 5, characterized in that: The information loading module retrieves a preset life factor information template from a storage unit according to treatment needs, generates specific life factor information by running an information processing algorithm through a microprocessor, generates electromagnetic waves or scalar waves of specific frequency and intensity according to the information generated by the autonomous information field generator, guides the autonomous information field into a plasma sample through a waveguide system, applies the autonomous information field to the plasma sample, loads the life factor information into the plasma, monitors the information loading process in real time through a sensor array to ensure accurate transmission and effective loading of information, processes sensor data through a data analysis unit to confirm the accuracy and effectiveness of information loading, and fine-tunes the information loading process according to monitoring results to ensure optimal results.

7. An information loading system according to claim 6, characterized in that: The scalar wave action module includes setting the frequency, intensity and wavelength of the scalar wave according to preset treatment needs and life factor information. The scalar field generator generates scalar waves of specific frequency and intensity according to the set parameters. The generated scalar wave is guided to the plasma sample through the waveguide system. The intensity and range of the scalar wave are adjusted by the focusing device to ensure that it covers the entire plasma sample. The scalar wave acts on the platelets in the plasma sample to enable them to undergo an orderly self-organization process and release a large amount of growth factors. The scalar wave activates the growth factors in the plasma to enable them to play a greater role in tissue repair and regeneration. The effect of the scalar wave is monitored in real time through the sensor array, including electric field changes, temperature changes and optical property changes. The sensor data is analyzed by the central processor to evaluate the effect of the scalar wave to ensure accurate transmission and effective loading of information.

8. An information loading system according to claim 7, characterized in that: The monitoring module comprises: The data acquisition unit includes a temperature sensor, a pressure sensor, a flow rate sensor, an electric field sensor and an optical sensor to monitor various parameters in the processing process in real time; collects the data monitored by the sensor and converts it into a digital signal through an analog-to-digital converter; The data processing unit performs preliminary processing and storage of the collected data to ensure the integrity and traceability of the data; through the communication interface, the collected data is transmitted to the central control unit for further data analysis and processing; The data analysis unit processes and analyzes the collected data in real time, evaluates the stability and safety of the processing process, generates monitoring reports and feedback information based on the analysis results, displays them on the display, and stores them in the storage unit; The abnormal monitoring and alarm unit will send out an alarm signal to alert the operator when an abnormal situation is detected. The alarm light and buzzer will send out visual and auditory alarm signals to remind the operator to take corresponding measures. The alarm information and processing process will be recorded to facilitate subsequent analysis and improvement.

9. The information loading system according to claim 8, characterized in that: The data analysis includes setting the frequency of the scalar wave according to the preset treatment needs and life factor information to ensure that it can effectively activate the growth factor within a specific range. The calculation formula is as follows: Among them, f set is the set frequency, f base is the initial frequency, Δf demand is the percentage change in demand frequency; According to the characteristics of the plasma sample and the treatment requirements, the intensity of the scalar wave is set to ensure that it acts on the plasma sample within an appropriate range. The calculation formula is as follows: Among them, E set To set the electric field strength, E base is the initial electric field strength, ΔE demand is the percentage change of required electric field strength; The wavelength of the scalar wave is set to ensure that its wavelength matches the characteristics of the plasma sample to maximize the activation effect of the growth factor. The calculation formula is as follows Among them, λ set is the set wavelength, f set is the set frequency and c is the speed of light.

10. The information loading system according to claim 8, characterized in that: The data analysis includes guiding the generated scalar wave to the plasma sample through the waveguide system to ensure the transmission path and efficiency of the wave. The calculation formula is as follows: or waveguide =the loss ·or focus , Among them, η waveguide is the waveguide system efficiency, η loss is the energy ratio of the scalar wave lost due to various loss factors when passing through the waveguide system, η focus To focus on efficiency; The focusing device adjusts the intensity and range of the scalar wave to ensure that it covers the entire plasma sample and maximizes the effect of activating the growth factor, calculated as follows: Among them, Focus set To set the focus parameters, Focus base is the initial focusing parameter, ΔFocus demand Focus on the percentage change of the parameter for the needs; The scalar wave acts on the plasma sample, especially the platelets, causing them to undergo an orderly self-organization process and release a large amount of growth factors. The calculation formula for the change in growth factor release is as follows: Among them, ΔG is the change in growth factor release, G base is the energy of the initial growth factor without scalar field stimulation, ΔG effect is the energy effect percentage of the growth factor acting on the scalar wave; According to the scalar wave activation of growth factors in plasma, it plays a greater role in tissue repair and regeneration. The growth factor activation efficiency calculation formula is as follows: Among them, A growth is the growth factor activation efficiency, A base Growth factor activation efficiency without scalar field stimulation, ΔA effect Scalar wave action growth factor activation efficiency effect percentage.

Images